CAI
Caris Life Sciences, Inc.
$17.47
-0.34 (-1.91%)
At close · Jul 7
Market Cap
$4.94B
Shares
282,680,695
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-05 | 2026-06-04 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-23 | 2026-06-04 | |
| 8-K | 2026-04-02 | 2026-04-01 | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-20 | — |
Showing 1–16 of 16 filings